KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to $144.0 million.

  • Bausch Health Companies' Change in Accured Expenses changed 0.0% to $144.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $232.0 million, marking a year-over-year decrease of 4604.65%. This contributed to the annual value of $357.0 million for FY2024, which is 12594.94% up from last year.
  • As of Q3 2025, Bausch Health Companies' Change in Accured Expenses stood at $144.0 million, which was down 0.0% from $163.0 million recorded in Q2 2025.
  • Bausch Health Companies' Change in Accured Expenses' 5-year high stood at $166.0 million during Q3 2023, with a 5-year trough of -$170.0 million in Q4 2021.
  • Moreover, its 5-year median value for Change in Accured Expenses was $49.0 million (2022), whereas its average is $40.5 million.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first tumbled by 30869.57% in 2022, then soared by 73750.0% in 2024.
  • Quarter analysis of 5 years shows Bausch Health Companies' Change in Accured Expenses stood at -$170.0 million in 2021, then skyrocketed by 127.65% to $47.0 million in 2022, then skyrocketed by 106.38% to $97.0 million in 2023, then tumbled by 75.26% to $24.0 million in 2024, then surged by 500.0% to $144.0 million in 2025.
  • Its last three reported values are $144.0 million in Q3 2025, $163.0 million for Q2 2025, and -$99.0 million during Q1 2025.